MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.

The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.

MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment ...

FDA rejects first psychedelic to treat PTSD, calling for more study In June, an independent committee of experts convened by the Food and Drug Administration recommended against approving the ...

MDMA studies suggested the psychedelic was effective, but strong opposition from a FDA advisory panel doomed Lykos Therapeutics' application.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study FILE- A sign is displayed for the Food and Drug Administration offices in Silver Spring, Md., on Dec. 10, 2020.

By MATTHEW PERRONE WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough… ...